Lv3
400 积分 2023-02-23 加入
TP53 and CDKN2A alterations define a poor prognostic subgroup in patients with nodal T follicular helper cell lymphoma
26天前
已完结
Clinicopathologic Analysis of Peripheral T-Cell Lymphoma, Follicular Variant, and Comparison With Angioimmunoblastic T-Cell Lymphoma
26天前
已完结
Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score
1个月前
已完结
Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified
1个月前
已完结
Burkitt-like lymphoma with 11q aberrations: a highly apoptotic and high-grade lymphoma
2个月前
已完结
Cytogenomic and Clinicopathologic Comparison of MYC-Positive and MYC-Negative High-Grade B-Cell Lymphoma With 11q Aberration in the Context of Other Aggressive Lymphomas With MYC Rearrangement
2个月前
已完结
A rare case of large B-cell lymphoma with IRF4 rearrangement and concomitant 11q aberrations: a diagnostic pitfall in the molecular era
2个月前
已完结
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration
2个月前
已完结
Proteogenomic Profiling of High-Grade B-Cell Lymphoma With 11q Aberrations and Burkitt Lymphoma Reveals Lymphoid Enhancer Binding Factor 1 as a Novel Biomarker
2个月前
已完结
[Clinicopathological features and molecular genetics of Burkitt-like lymphoma with 11q aberration]
2个月前
已完结
皖公网安备34019202002308
